Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-059034
Filing Date
2025-06-12
Accepted
2025-06-12 19:12:31
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2517800-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2517800-4_4seq1.xml 4 4021
  Complete submission text file 0001104659-25-059034.txt   5670
Mailing Address PO BOX 83216 GAITHERSBURG MD 20883-3216
Business Address
LAPOINTE ANTHONY GREGG (Reporting) CIK: 0001331860 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 251044305

Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)